European regulators are considering fining X more than $1 billion, after weighing the risks of further antagonizing Mr. Musk and President Trump.
Category: Regulation and Deregulation of Industry
-
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
-
Capital One Deal for Discover Clears Justice Dept. Hurdle
The department, during the Biden administration, initially said it had concerns about the merger of two of the largest credit card companies in the U.S.
-
Trump Administration Tallies Trade Barriers That Could Prompt Tariffs
The Office of the United States Trade Representative released a report Monday highlighting foreign trade barriers that could influence tariffs the president puts into effect this week.
-
Trump Allies Grill PBS and NPR During Congress Hearing
Dark pronouncements by Republicans about a “communist agenda” espoused by public media were intercut with lighter references to “Sesame Street” and “Curious George.”
-
U.S. Adds Export Restrictions to More Chinese Tech Firms Over Security Concerns
The additions included companies that are customers of Intel and Nvidia, and one firm that was the focus of a New York Times investigation last year.
-
Trump’s Crypto Venture Introduces a Stablecoin
World Liberty Financial, the crypto business created by President Trump and his sons, unveiled a cryptocurrency called a stablecoin, furthering his ties to an industry his administration regulates.
-
PBS and NPR prepare for a showdown with Congress.
Top executives from the public media networks are bracing for a hearing on Wednesday organized by Representative Marjorie Taylor Greene.
-
Trump Campaign Aide Chris LaCivita Sues The Daily Beast for Defamation
The lawsuit accuses the news site of knowingly publishing false information about how much Chris LaCivita, a Trump campaign manager, was paid by the campaign.
-
Emboldened by Trump, A.I. Companies Lobby for Fewer Rules
After the president made A.I. dominance a top priority, tech companies changed course from a meeker approach under the Biden administration.
-
FDA-Approved Artificial Blood Vessel Stirs Concerns
The F.D.A. approved an artificial vessel to restore blood flow in patients, despite its own scientists flagging questionable study results and potentially fatal ruptures of the product.